In this study, primary tumor, lymph node metastasis, distant metastasis, treatment methods, AFP level before treatment, and degree of cirrhosis were included, all of which were reflected in BCLC, but bilirubin level, international standardized ratio and other indicators for end-stage liver disease were not included. This evidence concerns the gene AFP and metastatic malignant neoplasm in the lymph nodes.